Medical Condition News

RSS

Faulty genetic pathway is a potent player in many types of allergies, say researchers

Newly published research by investigators at the Johns Hopkins Children's Center and the Johns Hopkins Institute of Genetic Medicine reveals that a faulty genetic pathway already known for its role in some connective tissue disorders is also a potent player in many types of allergies.

25 Jul 2013

Stopping cholesterol drugs may increase risk of Parkinson's disease

People who stop taking cholesterol drugs may be at an increased risk for developing Parkinson's disease, according to research that appears in the July 24, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.

25 Jul 2013

New clinic focuses on men with fast-growing prostate cancer

While every year about 30,000 men die of prostate cancer in the United States, the most common cause of death in men with prostate cancer is heart disease. That's because not all prostate cancers are the same. Some are slow-growing while others are very aggressive.

25 Jul 2013

National Parkinson Foundation releases Parkinson's Central app

The National Parkinson Foundation launched today Parkinson's Central, a free app specifically created for people living with Parkinson's disease and their families. This is the only comprehensive app for people living with Parkinson's.

24 Jul 2013

Ligand Pharmaceuticals, Ethicor Pharma sign license agreement for lasofoxifene

Ligand Pharmaceuticals Incorporated announces the signing of a license agreement with Ethicor Pharma Ltd. for the manufacture and distribution of the oral formulation of lasofoxifene in the European Economic Area, Switzerland and the Indian Subcontinent.

24 Jul 2013

Verastem's defactinib gets FDA orphan drug designation for treatment of mesothelioma

Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that lead cancer stem cell inhibitor, VS-6063 (defactinib), has received orphan drug designation from the U.S. Food and Drug Administration for use in the treatment of mesothelioma, a rare form of lung cancer.

24 Jul 2013

JACS reports study on LINX Reflux Management System for GERD treatment

An estimated 1 in 5 U.S. adults suffer from Gastroesophageal Reflux Disease (GERD), a chronic, often progressive disease that can cause debilitating symptoms and in certain cases lead to esophageal cancer.

24 Jul 2013

UL researcher receives €1.5 million to develop innovative treatments for bone-loss diseases

UL researcher, Dr David Hoey was announced as one of the recipients of the highly prestigious European Research Council (ERC) starting grants. Dr Hoey has been awarded €1.5 million to pursue cutting-edge fundamental research into developing innovative treatments for bone-loss diseases such as osteoporosis. Every 30 seconds a person suffers an osteoporosis-related hip fracture in the EU.

24 Jul 2013

Mortality rates declining among dialysis patients despite rise in coronary artery disease, study finds

A new study led by researchers at the University of Limerick’s Graduate Entry Medical School has found that deaths among dialysis patients are falling despite a rise in coronary artery disease.

24 Jul 2013

Child cancer survival: an interview with Prof Kathy Pritchard-Jones, University College London

Back in the early 1960s, just before chemotherapy really started to be used, only about 30% of children survived cancer. That was mainly because they had cancers that were amenable to surgery.

24 Jul 2013

Athletes should eat high fiber, low-fat food to maintain muscle, says OSU researcher

Athletes seeking a healthy performance weight should eat high fiber, low-fat food balanced with their training regimen in order to maintain muscle while still burning fat, according to a report by an Oregon State University researcher.

24 Jul 2013

Family and friends' fears of recurrence impact on patient's recovery after SAH

Researchers from Durham University and Kings College London (United Kingdom) and the University of Erlangen-N-rnberg (Germany) found that patients who have suffered a subarachnoid hemorrhage (SAH) may not recover psychosocially as well as expected if their significant other is excessively fearful about the possibility of SAH recurrence.

24 Jul 2013

Inovio plans to advance synthetic hTERT cancer vaccine into clinical trials in 2014

Inovio Pharmaceuticals, Inc. announced today that in a preclinical study with two animal models, Inovio's hTERT (human telomerase reverse transcriptase) DNA cancer vaccine administered with Inovio's CELLECTRA adaptive electroporation delivery technology generated robust and broad immune responses, broke the immune system's tolerance to its self-antigens, induced T-cells with a tumor-killing function, and increased the rate of survival.

24 Jul 2013

Study: Breathing oxygen during radiation therapy can delay tumor growth

A multidisciplinary team at UT Southwestern Medical Center has found that measuring the oxygenation of tumors can be a valuable tool in guiding radiation therapy, opening the door for personalized therapies that keep tumors in check with oxygen enhancement.

24 Jul 2013

SCCA physicians honored as "Top Doctors" for providing outstanding cancer care

Seattle Cancer Care Alliance doctors were recently honored by a judging panel of their peers for providing outstanding cancer care.

24 Jul 2013

3-D hydrogel approach to study aggressive and deadly forms of brain cancer

Human glioblastoma multiforme, one of the most common, aggressive and deadly forms of brain cancer, is notoriously difficult to study. Scientists have traditionally studied cancer cells in petri dishes, which have none of the properties of the brain tissues in which these cancers grow, or in expensive animal models.

24 Jul 2013

Researchers discover mechanism that prevents immune system from spinning out of control

A team led by a University of Arizona researcher has discovered a previously unknown mechanism that prevents the immune system from going into overdrive, shedding light not only on how our body controls its response to pathogens but on conditions such as autoimmune diseases, allergies and chronic inflammation as well.

24 Jul 2013

Smokers who try e-cigarettes to quit are younger and more motivated to quit, study finds

University of Hawaii Cancer Center Prevention and Control Program researchers Pallav Pokhrel, PhD and Thaddeus Herzog, PhD have found that smokers who use e-cigarettes as a tool to stop smoking tend to be younger and more motivated to quit smoking as compared to other smokers.

24 Jul 2013

Researchers provide new model for studying drug targets and therapies for AIH

A gene mutation disrupts the activity of certain immune cells and causes the immune system to erroneously attack the liver, according to a new animal study from the Icahn School of Medicine at Mount Sinai.

24 Jul 2013

Study examines incidence rates of type l diabetes in Finnish children

"The incidence of type l diabetes, one of the most prevalent chronic diseases in children, has increased worldwide," write Valma Harjutsalo, Ph.D., of the Diabetes Prevention Unit, Helsinki, Finland, and colleagues, who conducted a study to examine the incidence rates of T1D between 2006 and 2011 in Finnish children younger than 15 years as well as the 32-year trend (1980-2011).

24 Jul 2013

Medical Condition News

Faulty genetic pathway is a potent player in many types of allergies, say researchers

Stopping cholesterol drugs may increase risk of Parkinson's disease

New clinic focuses on men with fast-growing prostate cancer

National Parkinson Foundation releases Parkinson's Central app

Ligand Pharmaceuticals, Ethicor Pharma sign license agreement for lasofoxifene

Verastem's defactinib gets FDA orphan drug designation for treatment of mesothelioma

JACS reports study on LINX Reflux Management System for GERD treatment

UL researcher receives €1.5 million to develop innovative treatments for bone-loss diseases

Mortality rates declining among dialysis patients despite rise in coronary artery disease, study finds

Child cancer survival: an interview with Prof Kathy Pritchard-Jones, University College London

Athletes should eat high fiber, low-fat food to maintain muscle, says OSU researcher

Family and friends' fears of recurrence impact on patient's recovery after SAH

Inovio plans to advance synthetic hTERT cancer vaccine into clinical trials in 2014

Study: Breathing oxygen during radiation therapy can delay tumor growth

SCCA physicians honored as "Top Doctors" for providing outstanding cancer care

3-D hydrogel approach to study aggressive and deadly forms of brain cancer

Researchers discover mechanism that prevents immune system from spinning out of control

Smokers who try e-cigarettes to quit are younger and more motivated to quit, study finds

Researchers provide new model for studying drug targets and therapies for AIH

Study examines incidence rates of type l diabetes in Finnish children

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News